GleamWall
中文EN

FBIO Fortress Biotech, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1429260 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY12.3%
TTM net income YoY2,411.2%
TTM EPS YoY2,016.7%
Revenue 3-yr CAGR-4.7%
Net income 3-yr CAGR—

Margins

Gross margin66.2%
Operating margin-42.5%
Net margin143.0%
FCF margin—
EBITDA margin-41.9%

Returns

ROE92.8%
ROA43.4%
ROIC (approx.)-227.3%
Asset turnover0.30x

Leverage & solvency

Liabilities / assets36.8%
Debt / equity0.00x
Current ratio2.93x
Interest coverage-3.17x

Cash quality & payout

Operating cash flow / net income1.26x
Accruals ratio-11.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$63.26M$57.67M
Cost of revenue$20.92M$20.88M
Gross profit$42.34M$36.80M
R&D expense$11.90M$56.63M
SG&A expense$96.40M$87.73M
Operating income-$70.22M-$110.38M
Interest expense$10.11M$13.53M
Pretax income-$33.53M-$120.54M
Income tax-$620,000$312,000
Net income$6.82M-$46.00M
EBITDA-$69.82M-$109.34M
EPS (basic)-0.07-2.69
EPS (diluted)-0.07-2.69
Weighted avg. shares (diluted)27.90M20.78M
Balance sheet
Cash & equivalents$79.38M$58.81M
Receivables$29.78M$10.23M
Inventory$9.62M$14.43M
Current assets$123.84M$90.37M
PP&E, net$2.52M$3.26M
Intangibles$27.61M$31.86M
Total assets$185.55M$144.22M
Current liabilities$49.74M$71.40M
Long-term debt$54.49M$57.96M
Total debt$54.49M$57.96M
Total liabilities$123.36M$145.87M
Shareholders' equity$49.87M$22.74M
Net debt-$24.89M-$853,000
Shares outstanding31.36M27.91M
Cash flow statement
Operating cash flow-$65.78M-$80.19M
Capital expenditure—$0
Free cash flow—-$80.19M
Investing cash flow$10.12M-$15.00M
Financing cash flow$77.44M$70.64M
Depreciation & amortization$403,000$1.04M
Stock-based compensation$28.74M$32.62M
Dividends paid$664,000$694,000

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.